These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1012029)

  • 1. Bovine factor IX (Christmas factor).
    Fujikawa K; Davie EW
    Methods Enzymol; 1976; 45():74-83. PubMed ID: 1012029
    [No Abstract]   [Full Text] [Related]  

  • 2. The mechanism of activation of bovine factor IX (Christmas factor) by bovine factor XIa (activated plasma thromboplastin antecedent).
    Fujikawa K; Legaz ME; Kato H; Davie EW
    Biochemistry; 1974 Oct; 13(22):4508-16. PubMed ID: 4473201
    [No Abstract]   [Full Text] [Related]  

  • 3. Properties of bovine factor IX (Christmas factor).
    Davie EW; Fujikawa K; Kato H; Legaz ME
    Ann N Y Acad Sci; 1975 Jan; 240():34-42. PubMed ID: 234217
    [No Abstract]   [Full Text] [Related]  

  • 4. Heterogeneity of factor IX BM. Difference of cleavage sites by factor XIa and Ca2+ in factor IX Kashihara, factor IX Nagoya and factor IX Niigata.
    Yoshioka A; Ohkubo Y; Nishimura T; Tanaka I; Fukui H; Ogata K; Kamiya T; Takahashi H
    Thromb Res; 1986 Jun; 42(5):595-604. PubMed ID: 3487139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bovine factor XI (plasma thromboplastin antecedent).
    Koide T; Kato H; Davie EW
    Methods Enzymol; 1976; 45():65-73. PubMed ID: 1012019
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolation and characterization of bovine factor IX (Christmas factor).
    Fujikawa K; Thompson AR; Legaz ME; Meyer RG; Davie EW
    Biochemistry; 1973 Nov; 12(24):4938-45. PubMed ID: 4796921
    [No Abstract]   [Full Text] [Related]  

  • 7. Factor IX variants of hemophilia B. The effect of activated factor XI and the reaction product of factor VII and tissue factor on the abnormal factor IX molecules.
    Osterud B; Kasper CK; Prodanos C
    Thromb Res; 1979; 15(1-2):235-43. PubMed ID: 483278
    [No Abstract]   [Full Text] [Related]  

  • 8. Activation of bovine factor IX (Christmas factor) by factor XIa (activated plasma thromboplastin antecedent) and a protease from Russell's viper venom.
    Lindquist PA; Fujikawa K; Davie EW
    J Biol Chem; 1978 Mar; 253(6):1902-9. PubMed ID: 632245
    [No Abstract]   [Full Text] [Related]  

  • 9. Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VII and bovine tissue factor.
    Osterud B; Kasper CK; Lavine KK; Prodanos C; Rapaport SI
    Thromb Haemost; 1981 Feb; 45(1):55-9. PubMed ID: 7245126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human blood coagulation factor IX. Purification, properties, and mechanism of activation by activated factor XI.
    Osterud B; Bouma BN; Griffin JH
    J Biol Chem; 1978 Sep; 253(17):5946-51. PubMed ID: 681330
    [No Abstract]   [Full Text] [Related]  

  • 11. The mechanism of activation of bovine factor X (Stuart factor) by intrinsic and extrinsic pathways.
    Fujikawa K; Coan MH; Legaz ME; Davie EW
    Biochemistry; 1974 Dec; 13(26):5290-9. PubMed ID: 4474002
    [No Abstract]   [Full Text] [Related]  

  • 12. Preparation of factor IX deficient human plasma by immunoaffinity chromatography using a monoclonal antibody.
    Goodall AH; Kemble G; O'Brien DP; Rawlings E; Rotblat F; Russell GC; Janossy G; Tuddenham EG
    Blood; 1982 Mar; 59(3):664-70. PubMed ID: 7059674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional consequences of an arginine180 to glutamine mutation in factor IX Hilo.
    Monroe DM; McCord DM; Huang MN; High KA; Lundblad RL; Kasper CK; Roberts HR
    Blood; 1989 May; 73(6):1540-4. PubMed ID: 2713493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quantitative two-stage assay for factor IX (Christmas factor) using plasma from dogs with Christmas disease.
    Aronson DL; Dodds WJ; Mustafa AJ
    Thromb Diath Haemorrh; 1972 Jul; 27(3):529-34. PubMed ID: 4662614
    [No Abstract]   [Full Text] [Related]  

  • 15. Purification and characterization of an abnormal factor IX (Christmas factor) molecule. Factor IX Chapel Hill.
    Chung KS; Madar DA; Goldsmith JC; Kingdon HS; Roberts HR
    J Clin Invest; 1978 Nov; 62(5):1078-85. PubMed ID: 711853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of factor IX Chapel Hill: comparison to normal human factor IX.
    Chung KS; Goldsmith JC; Roberts HR
    Bibl Haematol; 1977; 44():68-74. PubMed ID: 617785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A simple analytic method of the activation mechanism of factor IX using Western blotting].
    Sakai T; Ohkubo Y; Tanaka I; Yamamoto K; Yoshioka A; Fukui H
    Rinsho Ketsueki; 1987 Jan; 28(1):47-52. PubMed ID: 3573331
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunoaffinity purification of factor IX (Christmas factor) by using conformation-specific antibodies directed against the factor IX-metal complex.
    Liebman HA; Limentani SA; Furie BC; Furie B
    Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3879-83. PubMed ID: 2408269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of factor IX by thrombin preparations in the absence of factor XI.
    Irwin JF; Mammen EF
    Thromb Res; 1976 Feb; 8(2):141-9. PubMed ID: 814650
    [No Abstract]   [Full Text] [Related]  

  • 20. An investigation of three patients with Christmas disease due to an abnormal type of factor IX.
    Denson KW; Biggs R; Mannucci PM
    J Clin Pathol; 1968 Mar; 21(2):160-5. PubMed ID: 4972271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.